期刊文献+

抑制巨噬细胞对异种胰岛移植物的作用

Effect of Pravastatin on the Survival of Islet Xenografts
下载PDF
导出
摘要 目的 观察普伐他汀 (pravastatin)对异种胰岛移植物存活的影响。方法 将猪→小鼠胰岛移植模型分成A组 (对照组 )、B组 (CsA组 )、C组 (普伐他汀组 )、D组 (CsA +普伐他汀组 )。观察指标 :移植物存活时间、病理检查、免疫组化染色、血清NO含量及移植物IFN γmRNA的表达。结果 A、B、C和D组移植物平均存活时间分别为 (6 .2±0 .82 )d、(9.2± 1 .92 )d、(7.2± 1 .30 )d及 (1 1 .2± 1 .76)d,D组存活时间明显长于其它 3组 (P<0 .0 5) ;D组移植物浸润细胞较其它 3组少。术后第 4天 ,血清NO水平A组为 (1 0 5 .8± 1 9.3)mmol/L ,明显高于B组的 (88.2± 2 1 .4)mmol/L(P<0 .0 5)、C组的 (70 .7± 1 7.8)mmol/L(P<0 .0 1 )及D组的 (56 .3± 1 6 .4)mmol/L(P<0 .0 1 ) ,出现移植排斥时 ,C、D组的血清NO水平分别为 (83 .7± 1 0 .6)mmol/L及 (71 .3± 1 3 .8)mmol/L ,仍较A组低 (P<0 .0 5) ,B组为 (1 0 4 .7± 1 6 .3)mmol/L ,与A组比较差异无显著性意义 (P>0 .0 5)。术后第 4天血清IFN γmRNA表达 ,D组为 2 3 .5± 4 .6 ,较A组的2 8.8± 4 .8低 (P<0 .0 5) ,而B、C组与A组间差异无显著性意义 (P>0 .0 5)。结论 普伐他汀能抑制巨噬细胞活性 ,延长异种胰岛移植物存活 。 Objective To study the effect of pravastatin on the survival of islet xenografts.Methods Pig to mouse islet transplantation was performed. The models were divided into 4 groups: group A (control); group B, treated with CsA; group C, treated with pravastatin; group D, treatment with combined CsA with pravastatin. The survival time (ST) of the grafts in each group were recorded. Histological examination was used to detect the inflammation and islet cells in the graft. The infiltrated cells were detected by immunohistochemistry with CD4 +, CD8 + and CD68 monoclonal antibody. The serum NO was measured. RT PCR was used in the test of IFN γ mRNA.Results The ST of group A,B,C,D was (6.2±0.82) d, (9.2±1.92) d, (7.2±1.30) d, (11.2±1.76) d respectively, the ST of group D was much longer than that of the other groups ( P < 0.05 ).Compared to that in other groups, less infiltrated cell in group D was found. On the 4th postoperative day, the serum NO in group A was (105.0±19.3) mmol/L,significantly higher than that in group B 〔(88.20±21.04) mmol/L〕, in group C 〔(70.7±17.8) mmol/L)〕 and in group D 〔(56.30±16.4) mmol/L〕. When rejection occurred, the serum NO in group C and D was (83.7±10.6) mmol/L and (71.3±13.8) mmol/L, also lower than that in group A ( P <0.05), the serum NO in group B was (104.7±16.3) mmol/L, compared that in group A, no significance was present ( P >0.05). On the 4th postoperative day, the serum expression of IFN γ mRNA in group D was 23.5±4.6, lower than that in group A (28.8±4.8), and no significance was present compared with that in group B and C. Conclusion Pravastatin can abate the role of macrophages, especially combined with Cyclosporine, and can prolong the survival of islet xenograft.
出处 《中国普外基础与临床杂志》 CAS 2003年第2期121-124,共4页 Chinese Journal of Bases and Clinics In General Surgery
关键词 巨噬细胞 异种胰岛移植物 普伐他汀 免疫组化 Pravastatin Macrophage Islet xenografts
  • 相关文献

参考文献7

  • 1Nagata M, Mullen Y, Matsuo S, etal. Destruction of islet isografts by severe nonspecific inflammation [J]. Transplant Proc, 1990, 22(2) : 855.
  • 2Kaufman DB, Platt JL, Rabe FL, et al. Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts [J]. J Exp Med,19901 172(1) :291.
  • 3Pukel C, Baquerizo H, Rabinovitch A. Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin, and interleukin 1 [J]. Diabetes, 1988, 37(1) :133.
  • 4Kroncke KD, Kolb-Bachofen V, Berschick B, et al. Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation [J]. Biochem Biophys Res Commun, 1991,175(3) : 752.
  • 5Arita S, Une S, Ohtsuka S, et al. Prevention of primary islet isograft nonfunction in mice with pravastatin [J]. Transplantation,1998; 65(11) : 1429.
  • 6Katznelson S, Wilkinson AH,Kobashigawa JA, et al. The effect of pravastatin on acute rejection after kidney transplantation a pilot study [J]. Transplantation, 1006, 61(10) : 1460.
  • 7Kobashigawa JA, Katznelson S, Laks H, et al. Effect of pravastatin on outcomes after cardiac transplantation [J]. N Engl J Med,1995, 333(10):621.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部